Market Share Movement Contracts Remain Of Interest To Prosecutor
Executive Summary
Market share movement contracts are potentially troubling if the end result is that patients are taken off therapy altogether, Philadelphia Associate U.S. Attorney James Sheehan suggested during the National Community Pharmacists Association legislative conference May 20 in Washington, D.C
You may also be interested in...
Medco In Settlement Talks With U.S. Attorney; Chance To Write PBM Rules?
Medco Health is in settlement discussions with the U.S. Attorney's Office in Philadelphia to resolve a five-year old investigation into pharmacy benefit management practices
Medco In Settlement Talks With U.S. Attorney; Chance To Write PBM Rules?
Medco Health is in settlement discussions with the U.S. Attorney's Office in Philadelphia to resolve a five-year old investigation into pharmacy benefit management practices
IG Compliance Guide Approach To CME, Consulting Concerns PhRMA
The Pharmaceutical Research & Manufacturers of America objects to the treatment of manufacturer-sponsored continuing medical education programs in the HHS Office of the Inspector General's final compliance guide